help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on March 11, 2004
Molecular Endocrinology, doi:10.1210/me.2003-0050
Molecular Endocrinology Vol. 0, No. 2004 200300501-
doi:10.1210/me.2003-0050
Copyright © 2004 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
18/6/1499    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fanelli, F.
Right arrow Articles by Themmen, A. P.N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fanelli, F.
Right arrow Articles by Themmen, A. P.N.

Submitted on February 10, 2003
Accepted on March 5, 2004

Insight into mutation-induced activation of the lutropin receptor: molecular simulations predict the functional behavior of engineered mutants at M398

Francesca Fanelli*, Miriam Verhoef-Post, Marianna Timmerman, Annelieke Zeilemaker, John W.M. Martens, and Axel P.N. Themmen

Dulbecco Telethon Institute and Department of Chemistry, University of Modena and Reggio Emilia, Modena, Italy. Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands

* To whom correspondence should be addressed. E-mail: fanelli{at}unimo.it.

In this study, molecular simulations have been combined with site-directed mutagenesis experiments to explore M398(2.43), a lutropin receptor (LHR) site in helix 2 susceptible to spontaneous activating mutations, and to develop a computational tool for predicting the functionality (i.e. active or non-active) of LHR mutants.

Site directed mutagenesis experiments engineered fifteen different substitutions for M389(2.43), which resulted in variable levels of constitutive activity, inversely correlated with the size of the replacing amino acid. This inverse correlation is suggested to be mediated by I460(3.46), M571(6.37) and Y623(7.53), the tyrosine of the NPxxY motif. In fact, size reduction at position 398(2.43), which is concurrent with constitutive receptor activity, releases the van der Waals interactions found in the wild type LHR between M398(2.43) and these three amino acids, resulting in structural modifications in the proximity to the E/DRY/W motif. An increment, above a threshold value, in the solvent accessibility of the cytosolic ends of helices 3 and 6 is the main structural feature shared by the active mutants of the LHR. This feature has been successfully used for predicting the functionality of the engineered mutants at M398(2.43), proving that molecular simulations can be useful for in silico screening of LHR mutants.




This article has been cited by other articles:


Home page
EndocrinologyHome page
X. Feng, T. Muller, D. Mizrachi, F. Fanelli, and D. L. Segaloff
An Intracellular Loop (IL2) Residue Confers Different Basal Constitutive Activities to the Human Lutropin Receptor and Human Thyrotropin Receptor through Structural Communication between IL2 and Helix 6, via Helix 3
Endocrinology, April 1, 2008; 149(4): 1705 - 1717.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
K. Angelova, F. Fanelli, and D. Puett
Contributions of Intracellular Loops 2 and 3 of the Lutropin Receptor in Gs Coupling
Mol. Endocrinol., January 1, 2008; 22(1): 126 - 138.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Zhang, Y.-X. Tao, G. L. Ryan, X. Feng, F. Fanelli, and D. L. Segaloff
Intrinsic Differences in the Response of the Human Lutropin Receptor Versus the Human Follitropin Receptor to Activating Mutations
J. Biol. Chem., August 31, 2007; 282(35): 25527 - 25539.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
G. Kleinau, M. Brehm, U. Wiedemann, D. Labudde, U. Leser, and G. Krause
Implications for Molecular Mechanisms of Glycoprotein Hormone Receptors Using a New Sequence-Structure-Function Analysis Resource
Mol. Endocrinol., February 1, 2007; 21(2): 574 - 580.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. Van Durme, F. Horn, S. Costagliola, G. Vriend, and G. Vassart
GRIS: Glycoprotein-Hormone Receptor Information System
Mol. Endocrinol., September 1, 2006; 20(9): 2247 - 2255.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
U. Ringkananont, J. Van Durme, L. Montanelli, F. Ugrasbul, Y. M. Yu, R. E. Weiss, S. Refetoff, and H. Grasberger
Repulsive Separation of the Cytoplasmic Ends of Transmembrane Helices 3 and 6 Is Linked to Receptor Activation in a Novel Thyrotropin Receptor Mutant (M626I)
Mol. Endocrinol., April 1, 2006; 20(4): 893 - 903.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Piersma, E. M. J. J. Berns, M. Verhoef-Post, A. G. Uitterlinden, I. Braakman, H. A. P. Pols, and A. P. N. Themmen
A Common Polymorphism Renders the Luteinizing Hormone Receptor Protein More Active by Improving Signal Peptide Function and Predicts Adverse Outcome in Breast Cancer Patients
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1470 - 1476.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Zhang, D. Mizrachi, F. Fanelli, and D. L. Segaloff
The Formation of a Salt Bridge Between Helices 3 and 6 Is Responsible for the Constitutive Activity and Lack of Hormone Responsiveness of the Naturally Occurring L457R Mutation of the Human Lutropin Receptor
J. Biol. Chem., July 15, 2005; 280(28): 26169 - 26176.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society